HSV-TK gene therapy(Avigen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHSV-TK gene therapy(Avigen)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionThymidine kinase modulators
TargetsThymidine kinase
Therapy Area/IndicationsBrain NeoplasmsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvigen Inc
Active IndicationsN/A
Inactive IndicationsBrain NeoplasmsGlioma

Other Information

ATC CodeN/A
Related LinksN/A